Three-Part Pricing to Reward Pharmaceutical Innovation and Increase Access- Case of PCSK9 Inhibitors
May 1, 2018, 00:00
10.1016/j.jval.2018.04.387
https://www.valueinhealthjournal.com/article/S1098-3015(18)30687-9/fulltext
Title :
Three-Part Pricing to Reward Pharmaceutical Innovation and Increase Access- Case of PCSK9 Inhibitors
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30687-9&doi=10.1016/j.jval.2018.04.387
First page :
Section Title :
Open access? :
No
Section Order :
1251